Deepverge (DVRG.L) Stock Price

Deepverge Price

LSE·CLOSED
0
​
Market closed

Revenue has compounded at 264.0% per year over the past 6 years to 9.30 M GBP. Deepverge's net margin stands at -28.8%, up from -9,290.3% several years earlier.

Deepverge stock price

Access this data via the Eulerpool API

Deepverge business model & stock analysis

Deepverge PLC is an emerging company specializing in the development of technologies for monitoring and analyzing the condition of environments and organisms. The company's history dates back to 2018 when it was founded as an innovation laboratory under the name Integumen. Deepverge PLC's business model combines bioscience and state-of-the-art technology. The company is divided into several divisions, each focused on specific application areas and customer needs. An important division of the company is the "Environment and Health" sector. Deepverge PLC develops innovative technologies for monitoring the quality of air, water, or soil. The company utilizes the analysis of microorganisms and the identification of pollutants to detect and minimize environmental damage. Another area of the company is "Life Sciences." Deepverge PLC focuses on the analysis of tissue samples and bodily fluids to detect and treat diseases early. The company is increasingly developing intelligent diagnostic tools based on artificial intelligence and machine learning. A further important area is "Consumer Health." Deepverge PLC develops innovative products and services to improve consumers' health and well-being. Offerings include monitoring apps for vital parameters and natural-based dietary supplements. Deepverge PLC also has some notable products on the market. One of them is the "Spectromic Skin Analysis System," which allows real-time monitoring and analysis of skin conditions. This system considers both visible and invisible parameters to detect changes early. One of Deepverge PLC's newest products is the "COVID-19 Real-Time PCR Surface Test." This test allows for the testing of surfaces for the presence of COVID-19 viruses and delivers real-time results. This is particularly important in public facilities and businesses to prevent the spread of the virus. Overall, Deepverge PLC is an innovative company that combines the possibilities of bioscience and modern technology. With its products and services, the company contributes to the early detection and resolution of environmental and health problems.

Frequently asked questions about Deepverge

The business model of Deepverge PLC revolves around providing innovative digital solutions for industries such as healthcare, personal care, and environmental monitoring. Deepverge PLC combines artificial intelligence, bioinformatics, and deep learning technologies to offer advanced data analytics and real-time insights. The company focuses on developing cutting-edge technologies that enable efficient monitoring, analysis, and management of data to drive actionable results. Deepverge PLC's business model aims to provide valuable solutions that enhance operational efficiency, regulatory compliance, and overall performance in various sectors.

Deepverge PLC is primarily active in the industries of digital pathology and healthcare. By leveraging sophisticated Artificial Intelligence and Machine Learning technologies, Deepverge PLC provides innovative solutions for medical diagnostics, environmental testing, and water monitoring. With a strong focus on improving global health, Deepverge PLC's cutting-edge technologies enable rapid, accurate, and cost-effective analysis of samples, empowering healthcare professionals and scientists with valuable insights. As a leader in its field, Deepverge PLC continues to drive advancements in digital pathology and contribute to the progress of medical research and diagnostics.

The main competitors of Deepverge PLC in the market are companies such as IBM, Microsoft, and Google.

Deepverge PLC is a leading technology company specializing in AI-driven digital pathology and skincare diagnostics. Founded in 2010, Deepverge has consistently evolved its expertise in artificial intelligence, machine learning, and microanalytics. The company's cutting-edge solutions provide innovative insights into disease detection, infection control, and environmental monitoring. Deepverge PLC's advanced technologies are utilized across various industries, including pharmaceuticals, healthcare, and consumer products. With a commitment to revolutionizing diagnostics and improving overall human health, Deepverge PLC continues to pioneer groundbreaking advancements in the field of digital pathology.

Deepverge PLC, a leading company in the field of artificial intelligence and digital pathology, has achieved several significant milestones. One noteworthy accomplishment is the development and implementation of AI-powered solutions for advanced real-time water and air monitoring. Through their Microtox technology, Deepverge PLC has successfully provided accurate and timely data analysis, enabling effective environmental management. Additionally, the company has established strategic partnerships with multinational corporations and academic institutions, fostering collaboration and driving innovation. Furthermore, Deepverge PLC has demonstrated impressive growth, expanding its market presence and establishing a strong global customer base. Overall, Deepverge PLC continues to make substantial strides in revolutionizing environmental monitoring and leveraging AI technology for sustainable solutions.

Deepverge PLC is primarily present in the United Kingdom.

Deepverge PLC represents a strong commitment to innovation, sustainability, and technological advancements. The company is focused on leveraging cutting-edge technologies to address critical challenges in industries such as healthcare, environmental monitoring, and consumer safety. With a forward-thinking corporate philosophy, Deepverge aims to revolutionize these sectors by providing smart solutions powered by AI, big data analytics, and IoT. By continuously pushing boundaries and striving for excellence, Deepverge PLC aims to create long-term value for its stakeholders and contribute to a more sustainable and connected world.

The Deepverge share (DVRG.L) is listed on 3 stock exchanges, including: London (DVRG.L), Frankfurt (4RG.F).

Deepverge PLC is a publicly traded company specializing in the development of artificial intelligence (AI) products and technologies. Its business model revolves around developing and selling a wide range of products and services across various markets. One of Deepverge's key divisions is its biowarfare division, which focuses on developing technologies and products for analyzing samples in the field of biomedicine. The company has developed a powerful "AI as a Service" offering that utilizes AI-based algorithms and advanced image processing technologies to swiftly and accurately analyze complex biological samples. Deepverge also has a subsidiary called Paraytec Ltd., which specializes in the development of miniature UV spectroscopy devices. Paraytec has created a miniature spectroscopy device that optimizes separation technologies in the production of biopharmaceuticals and monitors industrial processes. Another important division of Deepverge is its water analytics division, which concentrates on developing solutions for monitoring water quality. The company has developed a water monitoring platform called Microtox®️, which relies on AI-based technologies to rapidly and accurately identify contaminants and pollutants in water samples. Deepverge has also developed a robust portfolio of products and services for leveraging AI and machine learning in the pharmaceutical industry. The company has created a software called SYMPHONY that enables rapid and effective analysis of pharmaceutical data and samples. The software utilizes machine learning and AI to allow for better prediction of drug efficacy and toxicity, resulting in cost-effective and personalized drug development. In addition to these divisions, Deepverge also offers a range of services in the field of AI and machine learning, including the development of tailor-made AI solutions for businesses and organizations. The company's technology stacks enable companies to integrate the latest AI-based technologies and methods into their business processes to enhance efficiency and profitability. Overall, Deepverge has developed a diverse portfolio of products and services offered across various markets. The company has established itself as a leader in the field of AI and machine learning and is well-positioned to experience strong growth in the coming years by providing the latest technologies and solutions to tackle future challenges.

The revenue cannot currently be calculated for Deepverge.

The profit cannot currently be calculated for Deepverge.

The P/E ratio cannot be calculated for Deepverge at the moment.

The P/S cannot be calculated for Deepverge currently.

The Eulerpool Quality Score for Deepverge is 3/10.

The ISIN of Deepverge is GB00BMGWZY29. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Deepverge is A2QEPJ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Deepverge is DVRG.L. The ticker symbol is used to trade Deepverge shares on the stock exchange.

Fair ValueTerminal
148.30 GBP
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
1.03 M GBP
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Ireland
Currency
GBP
Initial public offering
Apr 5, 2017
ISIN
GB00BMGWZY29
Cusip
G4795Z114
Sedol
BMGWZY2
Market capitalization
1.14 M GBPMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.05
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-10.29 %
Gross Margin
57.12 %
EBIT Margin
-35.80 %
Net Margin
-28.82 %
EPS (Earnings Per Share)
-0.01 GBP
Net Debt / EBIT
-0.13
Debt/Equity
0.10
Last updated Oct 4, 2026, 8:44 PM

Deepverge Peer Group

Deepverge Ticker

FRANKFURT · 4RG.FLONDON · DVRG.LLONDON STOCK EXCHANGE · DVRG.L

Deepverge FIGI

DVRG:LN · BBG00GB92K69SKINGBX:XH · BBG00GD9MW78SKINGBX:XF · BBG00GD9MW96SKINGBX:XE · BBG00GD9MWC2SKINGBX:XL · BBG00GD9MWF9SKINGBX:XG · BBG00GD9MWG8SKINGBX:XO · BBG00GD9MWH7SKINGBX:XA · BBG00GD9MWN0SKINGBX:XT · BBG00GD9MWQ7SKINGBX:XW · BBG00GD9MWR6SKINGBX:XU · BBG00GD9MWS5SKINGBX:XV · BBG00GD9MWT4

All fundamentals and in-depth analysis of Deepverge

Our stock analysis for Deepverge stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Deepverge. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.